Skip to main content

Positron emission computed tomography

  • Chapter
Digital Cardiac Imaging

Abstract

Regional myocardial blood flow and substrate metabolism can be non-invasively evaluated and quantified with positron emission computed tomography (Positron-CT). Tracers of exogenous glucose utilization and fatty acid metabolism are available and have been extensively tested. Specific tracer kinetic models have been developed or are being tested so that glucose and fatty acid metabolism can be measured quantitatively by Positron-CT [1, 2]. Tracers of amino acid and oxygen metabolism are utilized in Positron-CT studies of the brain [3] and development of such tracers for cardiac studies are in progress [4]. Methods to quantify regional myocardial blood flow are also being developed [5]. Previous studies have demonstrated the ability of Positron-CT to document myocardial infarction [6, 7]. Experimental and clinical studies have begun to identify metabolic markers of reversibly ischemic myocardium [8, 9]. The potential of Positron-CT to reliably detect potentially salvageable myocardium and, hence, to identify appropriate therapeutic interventions is one of the most exciting applications of the technique.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Huang SC, Phelps ME, Hoffman EJ, Sideris K, Selin CJ, Kuhl DE: Non-invasive determintion of local cerebral metabolicrate of glucose in man. Am J Physiol 238: E69-E82, 1980.

    PubMed  CAS  Google Scholar 

  2. Huang SC, Schwaiger M, Selin C, Phelps ME, Schelbert HR: Tracer kinetic model of C-11 palmitate for estimating regional free fatty acid utilization in myocardium. J Nucl Med 24: P12, 1983.

    Google Scholar 

  3. Phelps ME, Mazziotta JC, Huang SC: Study of cerebral function with positron computed tomography. J Cerebral Blood Flow and Metab 2: 113–162, 1982.

    Article  CAS  Google Scholar 

  4. Henze E, Schelbert HR, Barrio JR, Egbert JE, Hansen HW, MacDonald NS, Phelps ME: Evaluation of myocardial metabolism with N-13 and C-11 labeled amino acids and positron computed tomography. J Nucl Med 23: 671–681, 1982.

    PubMed  CAS  Google Scholar 

  5. Huang SC, Schwaiger M, Carson RE, Henze E, Hoffman EJ, Phelps ME, Schelbert HR: An 0–15 water clearance method for quantitative regional myocardial blood flow measurements. J Nucl Med 23: P69, 1982.

    Google Scholar 

  6. Sobel BE, Weiss ES, Welch MJ, Siegel BA, Ter-Pogossian MM: Detection of remote myocardial infarction in patients with positron emission transaxial tomography and intravenous uC-palmitate. Circulation 55: 853, 1977.

    PubMed  CAS  Google Scholar 

  7. Geltman EM, Biello D, Welch MJ, Ter-Pogossian MM, Roberts R, Sobel BE: Characterization of non-transmural myocardial infarction by positron-emission tomography. Circulation 65: 747–755, 1982.

    Article  PubMed  CAS  Google Scholar 

  8. Schwaiger M, Ellison D, Johanson-Vinten J, Hansen H, Yeatman L, Schelbert HR: Sustained regional abnormalities in cardiac metabolism after transient ischemia in the chronic dog model. 1983 (In preparation).

    Google Scholar 

  9. Tillisch J, Marshall R, Schelbert H, Huang SC, Phelps ME: Reversibility of wall motion abnormalities; preoperative determination using positron tomography, 18fluorodeoxyglucose and 13NH3. Circulation 68: III-387, 1983.

    Google Scholar 

  10. Phelps ME: Emission computed tomography. Semin Nucl Med 7: 337–365, 1977.

    Article  PubMed  CAS  Google Scholar 

  11. Zielonka JS: Cardiac tomography. In: Holman BL, Parker J A (eds.), Computer-assisted cardiac nuclear medicine. Little, Brown amp Co, Boston, 1981, pp 445–477.

    Google Scholar 

  12. Muehllehner G, Colsher JG: Instrumentation. In: Ell PJ, Holman BL (eds.), Computed emission tomography. Oxford University Press, New York, 1982, pp 3–41.

    Google Scholar 

  13. Comar D, Berridge M, Maziere B, Crouzel C: Radiopharmaceuticals labeled with positron- emitting radioisotopes. In: Ell PH, Holman BL (eds.), Computed emission tomography. Oxford University Press, New York, 1982, pp 42–90.

    Google Scholar 

  14. Budinger TF, Derenzo SE, Huesman RH, Sherman LG, Moyer BR, Yano Y: Quantitative myocardial flow extraction data using gated ECT. J Nucl Med 21: P16, 1981.

    Google Scholar 

  15. Selwyn AP, Allan RM, L’Abbate A, Horlock P, Camici P, Clark J, O’Brien HA, Grant PM: Relation between regional myocardial uptake of rubidium-82 and perfusion: absolute reduction of cation uptake in ischemia. Am J Cardiol 50: 112–121, 1982.

    Article  PubMed  CAS  Google Scholar 

  16. Sokoloff L, Reivich M, Kennedy C, Des Rosiers MH, Patlak CS, Pettigrew KD, Sakuradao O, Shinohara M: The [14C]-deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure and normal values in the conscious and anesthetized albino rat. J Neurochem 28: 897–916, 1977.

    Article  PubMed  CAS  Google Scholar 

  17. Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE: Tomographic measurement of local cerebral glucose metabolicrate in humans with (F-18) 2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol 6: 371–388, 1979.

    Article  PubMed  CAS  Google Scholar 

  18. Krivokapich J, Huang SC, Phelps ME, Barrio JR, Wantanabe CR, Selin CE, Shine KI: Estima-tion of rabbit myocardial metabolic rate for glucose using fluorodeoxyglucose. Am J Physiol 243: H884–895, 1982.

    PubMed  CAS  Google Scholar 

  19. Marshall RC, Tillisch JH, Phelps ME, Huang SC, Carson RC, Henze E, Schelbert HR: Identi-fication and differentiation of myocardial ischemia and infarction in man with positron computed tomography 18F-labeled fluorodeoxy glucose and N-13 ammonia. Circulation 64: 766–778, 1983.

    Article  Google Scholar 

  20. Ratib O, Phelps ME, Huang SC, Henze E, Sellin CE, Schelbert HR: Positron tomography with deoxyglucose for estimating local myocardial metabolism. J Nucl Med 23: 577–586, 1982.

    PubMed  CAS  Google Scholar 

  21. Phelps ME, Hoffman EJ, Coleman RE, Welch MJ, Raichle ME, Weiss FS, Sobel BE, Ter-Pogossian MM: Tomographic images of blood pool and perfusion in brain and heart. J Nucl Med 17: 603–612, 1976.

    PubMed  CAS  Google Scholar 

  22. Schelbert HR, Phelps ME, Huang SC, MacDonald NS, Hansen H, Selin C, Kuhl DE: N-13 ammonia as an indicator of myocardial blood flow. Circulation 63: 1259–1272, 1981.

    Article  PubMed  CAS  Google Scholar 

  23. Bergmann ST, Hack S, Tewson T, Welch MJ, Sobel BE: The dependence of accumulation of 13NH3 by myocardium on metabolic factors and its implications for the quantitative assessment of perfusion. Circulation 61: 34–43, 1980.

    PubMed  CAS  Google Scholar 

  24. Krivokapich J, Huang SC, Phelps ME, MacDonald NS, Shine KI: Dependence of 13NH3 myocardial extraction and clearance on flow and metabolism. Am J Physiol 242 (Heart Circ Physiol II): H536-H542, 1982.

    PubMed  CAS  Google Scholar 

  25. Ziegler HW, Goreski CA: Kinetics of rubidium uptake in the working dog heart. Circ Res 29: 208–220, 1971.

    PubMed  CAS  Google Scholar 

  26. Mullani NA, Gould KL: First-pass measurements of regional blood flow with external detectors. J Nucl Med 24: 577–581, 1983.

    PubMed  CAS  Google Scholar 

  27. Mullani NA, Goldstein RA, Gould KL, Marani SK, Fisher DJ, O’Brien HA Jr, Loberg MD: Myocardial perfusion with rubidium-82. I. Measurement of extraction fraction and flow with external detectors. J Nucl Med 898–906, 1983.

    Google Scholar 

  28. Goldstein RA, Mullani NA, Marani SK, Fisher DJ, Gould KL, O’Brien HA: Myocardial perfusion with Rb-82. II. Effects of metabolic and pharmacologic interventions. J Nucl Med 24: 907–915, 1983.

    PubMed  CAS  Google Scholar 

  29. Carlsten A, Hallgren B, Jagenburg R, Svansborg A, Werko L: Myocardial metabolism of glucose, lactic acid, amino acids, and fatty acids in healthy human individuals at rest and at different work loads. Scand J Clin Labs Invest 13: 418–428, 1961.

    Article  CAS  Google Scholar 

  30. Wahlquist ML, Kaijer L, Lassers W, Carlson LA: Fatty acid as a determinant of myocardial substrate and oxygen metabolism in man at rest and during prolonged exercise. Acta Med Scan 193: 89–96, 1973.

    Article  Google Scholar 

  31. Schlant RC: Metabolism of the heart. In: Hurst JW, Schlant RC, Wenger NR (eds.), The heart, 4th ed. McGraw-Hill Book Co, Inc, New York, 1978, p 107.

    Google Scholar 

  32. Randle PJ, Tubbs PK: Carbohydrate and fatty acid metabolism. In: Berne RM, Sperelakis N, Geiger SR (eds), Handbook of physiology. Section 2: The cardiovascular system. Vol I: The heart. The American Physiological Society, Bethesda, MD, 1979, p 805.

    Google Scholar 

  33. Schelbert HR, Henze E, Schon HR, Keen R, Hansen H, Selin C, Huang SC, Barrio JR, Phelps ME: C-11 palmitate for the non-invasive evaluation of regional myocardial fatty acid metabolism with positron computed tomography. III. In vivo demonstration of the effects of substrate availability on myocardial metabolism. Am Heart J 105: 492–504, 1983.

    Article  PubMed  CAS  Google Scholar 

  34. Schelbert HR, unpublished.

    Google Scholar 

  35. Henze E, Grossman RG, Najafi A et al.: Measurement of C-11 palmitate kinetics after metabolic interventions in normals and patients with cardiomyopathy using positron emission computed tomography. Am J Cardiol 49: 1023, 1982.

    Article  Google Scholar 

  36. Henze E, Grossman EJ, Huang SC, Barrio JR, Phelps ME, Schelbert HR: Myocardial uptake and clearance of C-11 palmitic acid in man: effects of substrate availability and cardiac work. J Nucl Med 23: P12, 1982.

    Google Scholar 

  37. Keul J, Doll E, Steim H, Homburger H, Kern H, Reindell H: Uber den Stoffwechsel des menschlichen Herzens. I. Substratversorgung des gesunden Herzens in Ruthe wahrend und nach korperlicher Arbeit. Pfluegers Archiv 282: 1–27, 1965.

    Article  CAS  Google Scholar 

  38. Neely JR, Rovetto MJ, Oram JF: Myocardial utilization of carbohydrate and lipid. Prog Cardiovasc Dis 15: 289–329, 1972.

    Article  PubMed  CAS  Google Scholar 

  39. Ballard F, Danforth W, Nagel S, Bing R: Myocardial metabolism of fatty acids. J Clin Invest 39: 717–723, 1960.

    Article  PubMed  CAS  Google Scholar 

  40. Evans JR: Cellular transport of long chain fatty acids. Can J Biochem 42: 955–969, 1964.

    Article  PubMed  CAS  Google Scholar 

  41. Rothlin ME, Bing BJ: Extraction and release of individual free fatty acids by the heart and fat depots. J Clin Invest 40: 1380–1386, 1961.

    Article  PubMed  CAS  Google Scholar 

  42. Rose CP, Goresky CA: Constraints on the uptake of labeled palmitate by the heart. Circ Res 41 (4): 534–545, 1977.

    PubMed  CAS  Google Scholar 

  43. Hoffman EJ, Phelps ME, Weiss ES et al.: Transaxial tomographic imaging of canine myocardium with 11C-palmitic acid. J Nucl Med 18: 57–61, 1977.

    PubMed  CAS  Google Scholar 

  44. Klein MS, Goldstein RA, Welch MJ, Sobel BE: External assessment of myocardial metabolism with “C-palmitate in rabbit hearts. Am J Physiol (Heart Circ Physiol) 6: H51-H58, 1979.

    Google Scholar 

  45. Goldstein RA, Klein MS, Welch MJ, Sobel BE: External assessment of myocardial metabolism with C-11 palmitate in vivo. J Nucl Med 21: 342–348, 1980.

    PubMed  CAS  Google Scholar 

  46. Lerch RA, Ambos HD, Bergmann SR, Welch MJ, Ter-Pogossian MM, Sobel BE: Localization of viable, ischemic myocardium by positron-emission tomography with nC-palmitate. Circulation 64: 689–699, 1981.

    Article  PubMed  CAS  Google Scholar 

  47. Schon HR, Schelbert HR, Robinson G, Najafi A, Huang SC, Hansen H, Barrio J, Kuhl DE, Phelps ME: C-11 labeled palmitic acid for the non-invasive evaluation of regional myocardial fatty acid metabolism with positron computed tomography. I. Kinetics of C-11 palmitic acid in normal myocardium. Am Heart J 103: 532–47, 1982.

    Article  PubMed  CAS  Google Scholar 

  48. Schon HR, Schelbert HR, Najafi A, Hansen H, Robinson GR, Huang SC, Barrio J, Phelps ME: C-11 labeled palmitic acid for the non-invasive evaluation of regional myocardial fatty acid metabolism with positron computed tomography. II. Kinetics of C-11 palmitic acid in acutely ischemic myocardium. Am Heart J 103: 548–561, 1982.

    Article  PubMed  CAS  Google Scholar 

  49. Heymann MA, Payne BD, Hoffman JIE et al.: Blood flow measurements with radionuclide- labeled particles. Prog Cardiovasc Dis 20: 55–79, 1977.

    Article  PubMed  CAS  Google Scholar 

  50. Most AS, Brachfield N, Gorlin R, Wahren J: Free fatty acid metabolism of the human heart at rest. J Clin Invest 48: 1177–1188, 1969.

    Article  PubMed  CAS  Google Scholar 

  51. Marshall RC, Huang SC, Nash WW, Schelbert HR, Phelps ME: Tracer kinetic analysis of 2–3H-glucose to measure myocardial glucose transport and phosphorylation. Circulation 68: III-67, 1983.

    Google Scholar 

  52. Gould KL: Assessment of coronary stenosis with myocardial perfusion imaging during pharmacologic coronary vasodilation. IV. Limits of detection of stenosis with idealized experimental cross-sectional myocardial imaging. Am J Cardiol 42: 761–8, 1978.

    Article  PubMed  CAS  Google Scholar 

  53. Gould KL, Schelbert HR, Phelps ME, Hoffman EJ: Non-invasive assessment of coronary stenoses with myocardial perfusion imaging during pharmacologic coronary vasodilation. V. Detection of 47 percent diameter coronary stenosis with intravenous nitrogen-13 ammonia and emission-computed tomography in intact dogs. Am J Cardiol 43: 200–208, 1979.

    Article  PubMed  CAS  Google Scholar 

  54. Schelbert HR, Wisenberg G, Phelps ME, Gould KL, Henze E, Hoffman EJ, Gomes A, Kuhl DE: Non-invasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilation. VI. Detection of coronary artery disease in human beings with intravenous N-13 ammonia and positron computed tomography. Am J Cardiol 49: 1197–1207, 1982.

    Article  PubMed  CAS  Google Scholar 

  55. Hoffman EJ, Huang SC, Phelps ME: Quantitation in positron emission computed tomography. 1. Effect of object size. J Comp Assist Tomogr 3 (3): 299–308, 1979.

    Article  CAS  Google Scholar 

  56. Deanfield JE, Selwyn AP, Chierchia S, Maseri A, Ribeiro P, Krikler S, Morgan M: Myocardial ischemia during daily life in patients with stable angina: its relation to symptoms and heart rate changes. Lancet 2: 753–758, 1983.

    Article  PubMed  CAS  Google Scholar 

  57. Deanfield J, Shea M, Wilson R, Horlock P, Selwyn A: Mental stress and ischemia in patients with coronary disease. Circulation 68: III-258, 1983.

    Google Scholar 

  58. Parodi O, Schelbert HR, Schwaiger M, Hansen H, Selin C, Hoffman EJ: Artifactual reductions of segmental indicator tissue concentrations on tomographic images of the heart caused by regional wall motion abnormalities. 1984 (in preparation).

    Google Scholar 

  59. Liedtke AJ: Alterations of carbohydrate and lipid metabolism in the acutely ischemic heart. Prog in Cardiovas Dis 23 (5): 321–336, 1981.

    Article  CAS  Google Scholar 

  60. Opie LH, Owen P, Riemersma RA: Relative rates of oxidation of glucose and free fatty acids by ischemic and non-ischemic myocardium after coronary ligation in the dog. Eur J Clin Invest 3: 419, 1973.

    Article  PubMed  CAS  Google Scholar 

  61. Schelbert HR, Henze E, Keen R, Schon HR, Hansen H, Selin C, Huang SC, Barrio JR, Phelps ME: C-11 palmitate for the non-invasive evaluation of regional myocardial fatty acid metabolism with positron computed tomography. IV. In vivo evaluation of acute, experimentally induced myocardial ischemia. Am Heart J 106 (4): 736–750, 1983.

    Article  PubMed  CAS  Google Scholar 

  62. Camici P, Kaskl JC, Shea MS, Selwyn AP, Jones T, Maseri A: Increased myocardial glucose utilization in exertional angina. Circulation 68: III-324, 1983.

    Google Scholar 

  63. Schelbert HR, Henze E, Guzy PM, Don-Michael TA, Schwaiger M, Barrio JR: Non-invasive evaluation of regional myocardial fatty acid metabolism in man with C-11 palmitic acid and Positron-CT. J Nucl Med 24: P12, 1983.

    Google Scholar 

  64. Weiss ES, Ahmed SA, Welch MS, Williamson JR, Ter-Pogossian MM, Sobel BE: Quantification of infarction in cross-sections of canine myocardium in vivo with positron-emission transaxial tomography and nC-palmitate. Circulation 55: 66–73, 1977.

    PubMed  CAS  Google Scholar 

  65. Ter-Pogossian MM, Klein MS, Markham J, Roberts R, Sobel BE: Regional assessment of myocardial metabolic integrety in vivo by positron-emission tomography with nC-labeled palmitate. Circulation 61: 242–255, 1980.

    PubMed  CAS  Google Scholar 

  66. Billadello JJ, Smith JL, Ludbrook PA, Tiefenbrunn AJ, Jaffee AS, Sobel BE, Geltman EM: Implications of ‘reciprocal’ ST segment depression associated with acute myocardial infarction identified by positron tomography. J Amer Col Cardiol 2 (4): 616–624, 1983.

    Article  CAS  Google Scholar 

  67. Bergmann SR, Lerch RA, Fox KA, Ludbrook PA, Welch MJ, Ter-Pogossian MM, Sobel BE: Temporal dependence of beneficial effects of coronary thrombolysis characterized by positron tomography. Am J Med 73: 573–581, 1982.

    Article  PubMed  CAS  Google Scholar 

  68. Ludbrook PA, Geltman EM, Tiefenbrunn AJ, Jaffe AS, Sobel BE: Restoration of regional myocardial metabolism by coronary thrombolysis in patients. Circulation 68: III-325, 1983.

    Google Scholar 

  69. Braunwald E, Kloner RA: The stunned myocardium: prolonged postischemic ventricular dys-function. Circulation 66 (6): 1146–1149, 1982.

    Article  PubMed  CAS  Google Scholar 

  70. Shabetai R: Cardiomyopathy: How far have we come in years, how far yet to go? J Amer Coll Cardiol 1: 252–263, 1983.

    Article  CAS  Google Scholar 

  71. Geltman EM, Smith JL, Beecher D, Ludbrook PA, Ter-Pogossian MM, Sobel BE: Altered regional myocardial metabolism in congestive cardiomyopathy detected by positron tomography. Am J Med 74: 773–785, 1983.

    Article  PubMed  CAS  Google Scholar 

  72. Eisenberg JD, Smith JL, Sobel BE, Geltman EM: Differentiation of ischemic from non-ischemic cardiomyopathy by positron emission tomography (PET). Circulation 68: III-386, 1983.

    Google Scholar 

  73. Brooke MH: A clinician’s view of neuromuscular diseases. The Williams amp Wilkins Co, Baltimore, 1979.

    Google Scholar 

  74. Perloff JK, DeLeon AC Jr, Doherty D: The cardiomyopathy of progressive muscular dystrophy. Circulation 33: 625–648, 1966.

    PubMed  CAS  Google Scholar 

  75. Perloff JK, Henze E, Schelbert HR: Alterations in regional myocardial metabolism, perfusion and wall motion in Duchenne’s muscular dystrophy studied by radionuclide imaging. Circulation 69: 33–42, 1983.

    Article  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Martinus Nijhoff Publisher, Dordrecht

About this chapter

Cite this chapter

Grover, M., Schelbert, H.R. (1985). Positron emission computed tomography. In: Buda, A.J., Delp, E.J. (eds) Digital Cardiac Imaging. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-4996-6_14

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-4996-6_14

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-8712-4

  • Online ISBN: 978-94-009-4996-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics